Please login to the form below

Not currently logged in
Email:
Password:

hepatitis

This page shows the latest hepatitis news and features for those working in and with pharma, biotech and healthcare.

Long-serving R&D head Bischofberger to leave Gilead

Long-serving R&D head Bischofberger to leave Gilead

During his tenure he oversaw the launch of a raft of HIV and hepatitis C and B therapies. ... McHutchison has been at Gilead since 2010, joining the company from Duke University Medical Center, and has been a key figure in the company hepatitis

Latest news

More from news
Approximately 120 fully matching, plus 363 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    on hepatitis C treatments and the recent introduction of the Budget Impact Test.

  • No incentive for a cure No incentive for a cure

    Hepatitis C virus treatments like Maviret from AbbVie, which cures people with hard-to-treat genotype 3 after an 8. ... This is the route the NHS in the UK has taken with innovative hepatitis C treatments; it will only pay for the medication if a patient

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

  • Pharma deals continue to slide Pharma deals continue to slide

    On the other hand, Gilead has been under pressure from investors to do something with its $36.6bn cash, especially as its sales, largely driven by hepatitis C products, fell by

More from intelligence
Approximately 3 fully matching, plus 43 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics